美國胡澤民中醫類風濕醫療集團外景和大廳

中醫在美國
中醫藥走出國門，是一個漫長而艱難的過程。雖說中醫對外輸出理論上已有數千年歷史，但真正的成功只在古代，那是中華文明全面領先的時代，以宏大的文明成就作為背景，中醫藥的成功輸出是水到渠成。

但在脫離文化的基礎性推動之后，中醫藥僅以單純的醫藥和技術層面的對外輸出，卻是困難重重。尤其是現代社會，對于醫療及藥品的管理尤其嚴格，在以現代西醫西藥為管理標準的前提下，以典型的東方模糊理念發展起來的中醫藥，完全不是同一個理念范疇。這無疑是一個困局。

但是隨著華人在世界范圍內的遷徙范圍越來越廣，他們以個體性、自發性為主要方式，將中醫藥帶到了世界各地。在越來越多的人認識到中醫藥無法替代的效果之后仍選擇性忽視其存在，已無異于掩耳盜鈴。在不更改條文的基礎上，便有了將中藥當成食品來管理的處理辦法。

類風濕之困
眾所周知，類風濕關節炎是世界五大頑癥之一，目前西藥對此病的功效也僅僅是抑制和緩解病痛。但是在攻克疑難雜癥方面，中藥的效力總是出乎意料。胡澤民先生獨創的特色療法更是其中翹楚。

與其他中醫治療類風濕、強直性脊柱炎的方法不同，一直在苦思如何破解中醫困局的胡澤民早就把標準化、規范化作為了自己研究的重要方向，這是解決中醫因強調個體化、差異化而很難適應現代管理制度難題的可行途徑，也是中醫真正走向世界必須要跨越的一個難關。

在對眾多病例開展追蹤反饋和系統研究之后，胡澤民發現中藥對同一病癥治療效果的個體化差異并不是很明顯，在對自身研創的特色療法多次細化調整之后，成功地對類風濕、強直性脊柱炎實施了標準化治療。在不降低療效的前提下，大大提高了治療的可靠性與效率。

可以說，在實現標準化、規范化治療后，在類風濕及強直性脊柱炎治療領域，胡澤民所取得的成就已經完全具備了面向海外拓展的實力。

據文獻報道，美國白人的類風濕發病率為0.5~1%，美國印第安人約為5.3%，明顯高于中國國內0.32~0.4%的發病率。疾病的痛苦是公平的，它不會因為你的人種、國籍而有所不同。對于海外拓展的第一步，胡澤民在多方面考慮之后，毅然選擇了美國。

在這樣的一個背景之下，投資達1000萬美元的美國胡澤民中醫類風濕醫療集團在洛杉磯波莫納市成立了。事實上，在集團成立的前前后后，胡澤民就以其個人成就和名望，在當地引發了大量關注。在此基礎上，集團開辦的第一家醫院——美國胡澤民中醫類風濕病醫院開業伊始便擁有了相當的知名度，前來咨詢和接受康復服務的人絡繹不絕。而且首批患者的病情已經獲得了明顯改善，“胡氏療法”以完美的表現打開了海外市場的大門！

美利堅中醫宏圖
海外市場的大門打開了，展現在胡澤民面前的是廣闊的天地。在類風濕治療領域，中醫有其不可替代的地位。這些以前只停留在中國國內醫療領域內的認識，已經開始在國外漸漸得到認可，這才是他真正感到欣慰的。

通過開辦醫療機構，推廣全新的中醫醫療方式，讓國外醫患認識全新的中醫中藥，讓越來越多不分國籍、不分人種的類風濕、強直患者重獲健康，這是胡澤民的宿愿。

在第一家醫院得到認可之后，胡澤民把眼光投向了更遠的方向。

在胡澤民看來，格局大小是決定發展層次的一個關鍵指標。開辦第一家醫院只是他在美國發展藍圖的第一步。這一步走踏實了，后面的步子才能穩定而快捷。在他心里面的美國地圖上，以洛杉磯為起點，紐約、波士頓、芝加哥、費城、舊金山、亞特蘭大……以這些主要城市為節點，再全面鋪開，最終形成一個投資5000萬美元，200個醫療網點的胡澤民中醫類風濕醫療網絡。

Hu Zemin’s blueprint
TCM in US
 It is a long journey to introduce traditional Chinese medicine to the world. Although TCM output already went through thousands of years, it only succeeded in ancient times. At that time Chinese civilization was in a prosperous era and TCM was the excellent medical method.
 But without the cultural background, it is not an easy task to spread TCM to other countries. In modern times, for the strict regulations and rules are based on western medicine, and the conception of TCM is very different from western medicine, TCM’s output is in a dilemma.
 In the Chinese worldwide migration process, they brought along Chinese herbs. More and more people realized the irreplaceable effect of TCM and they cannot ignore it anymore. Then there came out a method to treat Chinese herbs as food to avoid the trouble of changing the rules.

The Trouble of RA and AS
As one of the five major chronic and stubborn diseases, the rheumatoid disease or the ankylosing spondylitis has always been the problem of the medical community and lacks a method. The present standard of rehabilitation is to inhibit the disease and eliminate pain to ensure patients’ normal life and work. However, the “Mr. Hu Herb Treatment of Rheumatoid Arthritis” has a unique standard of helping patients get recovery and reduce the side effect at the maximum level. After research, Mr. Hu ultimately learnt from the idea of stimulating the state of the pregnant women to improve his start-up of the formula. After his personal reagent and many clinical validations, the “Mr. Hu Herb Treatment of Rheumatoid Arthritis” magically cured his serous rheumatoid disease and helped 100, 000 patients who suffered the disease or the ankylosing spondylitis.
Through feedback and research, Hu Zemin found that the individual difference to the treatment is not obvious. "Hu’s therapy” successfully standardized the treatment of rheumatoid disease and improved the reliability and efficiency of treatment without influencing the effect, which made the way for its overseas expanding.
According to the data, the incidence of rheumatoid is 0.5 ~ 1% in American whites, about 5.3% in American Indians, significantly higher than the incidence of 0.32 ~ 0.4% in China. After many research, Hu Zemin chose the United States as the first destination for his overseas expanding.
Thus, Hu Zemin TCM rheumatoid medical group was founded in Los Angeles, Pomona city, and the first traditional Chinese medicine (TCM) hospital opened afterwards. "The Hu’s therapy" opened the door of  overseas market with perfect performance!

The Promising Future
Since the overseas market was opened, it is a grand new era for Hu Zemin TCM rheumatoid medical group. After the hospital was recognized, Hu Zemin began planning the further plan.
The hospital in Los Angeles is just the first step, and a successful first step could make way for the future. Take Los Angeles as the starting point, New York, Boston, Chicago, Atlanta, Philadelphia, San Francisco are all on the list. Eventually it would form a network of $50 million, with 200 medical branches.